Compare Stocks: PBM vs. AMGN vs. GILD vs. VRTX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
PBMAMGNGILDVRTX
Market Snapshot
Current market context for the selected companies.
PBM
$4.32
Market Cap
$2.59M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
AMGN
$440.10
Market Cap
$239.09B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
GILD
$148.02
Market Cap
$184.47B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
VRTX
$547.20
Market Cap
$140.13B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | PBM | AMGN | GILD | VRTX |
|---|---|---|---|---|
| 1 Month | +36.7% | +12.0% | +10.2% | +11.6% |
| 1 Month vs SPY | +33.4% | +8.6% | +6.9% | +8.3% |
| 3 Months | -0.0% | +31.0% | +10.7% | +25.2% |
| 3 Months vs SPY | -2.0% | +29.0% | +8.7% | +23.1% |
| 6 Months | +68.8% | +14.5% | +0.6% | +13.3% |
| 6 Months vs SPY | +58.3% | +4.1% | -9.8% | +2.8% |
| 1 Year | -96.6% | +52.6% | +29.7% | +40.7% |
| 1 Year vs SPY | -115.7% | +33.4% | +10.5% | +21.5% |
| 2 Years | -100.0% | +33.7% | +97.0% | +12.6% |
| 2 Years vs SPY | -136.5% | -2.8% | +60.5% | -24.0% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.